Phase 1 Study of CM082 in Patients With wAMD

NCT02452385 · clinicaltrials.gov ↗

PHASE1

Phase

SUSPENDED

Status

56

Enrollment

INDUSTRY

Sponsor class

Stopped Sponsor requirements

Conditions

Age-Related Macular Degeneration

Interventions

DRUG: CM082 tablet

Sponsor

AnewPharma

Collaborators

[object Object]